Literature DB >> 7115559

Pulse corticosteroid therapy for refractory thrombocytopenia in systemic lupus erythematosus.

D P Lurie, M B Kahaleh.   

Abstract

A patient with systemic lupus erythematosus and severe thrombocytopenia was refractory to therapy with prednisone, alone or in combination with cyclophosphamide or vincristine. Intravenous pulse therapy with methylprednisolone was associated with an increased platelet count from 4,000/mm3, to 52,000/mm3, but the response was short-lived. A second course of pulse therapy was also successful, and splenectomy was safely performed. The platelet count has remained normal for 15 months after surgery, allowing prednisone to be tapered and discontinued. Intravenous pulse therapy with methylprednisolone may be a safe alternative in preparing patients with profound, refractory thrombocytopenia for splenectomy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115559

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Splenectomy for thrombocytopenia associated with systemic lupus erythematosus in 11 Chinese patients.

Authors:  Ruixia Li; Gang Liu; Kai Wang; Yixin Liu; Qibing Xie; Yi Liu; Guixiu Shi
Journal:  Rheumatol Int       Date:  2009-11-03       Impact factor: 2.631

2.  A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.

Authors:  J C Edwards; M L Snaith; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

3.  Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus.

Authors:  Y Nancy You; Ayalew Tefferi; David M Nagorney
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

4.  Hematological disorders in patients with systemic lupus erythematosus.

Authors:  Fozya Bashal
Journal:  Open Rheumatol J       Date:  2013-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.